These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8860990)

  • 1. Involvement of tissue inhibitors of metalloproteinases (TIMPS) during matrix metalloproteinase activation.
    Nagase H; Suzuki K; Itoh Y; Kan CC; Gehring MR; Huang W; Brew K
    Adv Exp Med Biol; 1996; 389():23-31. PubMed ID: 8860990
    [No Abstract]   [Full Text] [Related]  

  • 2. New leads to cancer, arthritis therapies.
    Hagmann M
    Science; 1999 Jun; 284(5420):1600-1. PubMed ID: 10383332
    [No Abstract]   [Full Text] [Related]  

  • 3. An analysis of the conformational changes that accompany the activation and inhibition of gelatinase A.
    Crabbe T; Kelly SM; Price NC
    FEBS Lett; 1996 Feb; 380(1-2):53-7. PubMed ID: 8603746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases.
    Butler GS; Will H; Atkinson SJ; Murphy G
    Eur J Biochem; 1997 Mar; 244(2):653-7. PubMed ID: 9119036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed.
    Morgunova E; Tuuttila A; Bergmann U; Isupov M; Lindqvist Y; Schneider G; Tryggvason K
    Science; 1999 Jun; 284(5420):1667-70. PubMed ID: 10356396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMP-2: expression, activation and inhibition.
    Corcoran ML; Hewitt RE; Kleiner DE; Stetler-Stevenson WG
    Enzyme Protein; 1996; 49(1-3):7-19. PubMed ID: 8796994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between progelatinase A and TIMP-2.
    Hayakawa T; Fujimoto N; Ward RV; Iwata K
    Ann N Y Acad Sci; 1994 Sep; 732():389-91. PubMed ID: 7978817
    [No Abstract]   [Full Text] [Related]  

  • 8. Endothelial-cell-stimulating angiogenesis factor (ESAF) activates progelatinase A (72 kDa type IV collagenase), prostromelysin 1 and procollagenase and reactivates their complexes with tissue inhibitors of metalloproteinases: a role for ESAF in non-inflammatory angiogenesis.
    McLaughlin B; Weiss JB
    Biochem J; 1996 Aug; 317 ( Pt 3)(Pt 3):739-45. PubMed ID: 8760357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of 92 kDa and 72 kDa progelatinases to insoluble elastin modulates their proteolytic activation.
    Emonard H; Hornebeck W
    Biol Chem; 1997; 378(3-4):265-71. PubMed ID: 9165080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation of the active site glutamic acid of human gelatinase A: effects on latency, catalysis, and the binding of tissue inhibitor of metalloproteinases-1.
    Crabbe T; Zucker S; Cockett MI; Willenbrock F; Tickle S; O'Connell JP; Scothern JM; Murphy G; Docherty AJ
    Biochemistry; 1994 May; 33(21):6684-90. PubMed ID: 7911325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2.
    Sato H; Kinoshita T; Takino T; Nakayama K; Seiki M
    FEBS Lett; 1996 Sep; 393(1):101-4. PubMed ID: 8804434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Processing of a precursor of 72-kilodalton type IV collagenase/gelatinase A by a recombinant membrane-type 1 matrix metalloproteinase.
    Kinoshita T; Sato H; Takino T; Itoh M; Akizawa T; Seiki M
    Cancer Res; 1996 Jun; 56(11):2535-8. PubMed ID: 8653693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue inhibitors of metalloproteinases: evolution, structure and function.
    Brew K; Dinakarpandian D; Nagase H
    Biochim Biophys Acta; 2000 Mar; 1477(1-2):267-83. PubMed ID: 10708863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence quenching studies of matrix metalloproteinases (MMPs): evidence for structural rearrangement of the proMMP-2/TIMP-2 complex upon mercurial activation.
    Stack MS; Itoh Y; Young TN; Nagase H
    Arch Biochem Biophys; 1996 Sep; 333(1):163-9. PubMed ID: 8806767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The recombinant catalytic domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) induces activation of progelatinase A and progelatinase A complexed with TIMP-2.
    Lichte A; Kolkenbrock H; Tschesche H
    FEBS Lett; 1996 Nov; 397(2-3):277-82. PubMed ID: 8955363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The binding of gelatinases A and B to type I collagen yields both high and low affinity sites.
    Allan JA; Docherty AJ; Murphy G
    Ann N Y Acad Sci; 1994 Sep; 732():365-6. PubMed ID: 7978809
    [No Abstract]   [Full Text] [Related]  

  • 17. Progelatinase B forms from human neutrophils. complex formation of monomer/lipocalin with TIMP-1.
    Kolkenbrock H; Hecker-Kia A; Orgel D; Kinawi A; Ulbrich N
    Biol Chem; 1996; 377(7-8):529-33. PubMed ID: 8922288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Matrix metalloproteinases and their biological functions].
    Solov'eva NI
    Bioorg Khim; 1998 Apr; 24(4):245-55. PubMed ID: 9612566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between tissue inhibitor of metalloproteinases-2 and progelatinase A: immunoreactivity analyses.
    Fujimoto N; Ward RV; Shinya T; Iwata K; Yamashita K; Hayakawa T
    Biochem J; 1996 Feb; 313 ( Pt 3)(Pt 3):827-33. PubMed ID: 8611162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The matrix metalloproteinases and their inhibitors.
    Murphy G; Docherty AJ
    Am J Respir Cell Mol Biol; 1992 Aug; 7(2):120-5. PubMed ID: 1497900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.